In multiple myeloma, ROR2 has been shown to exert a pivotal role in cancer cell adhesion; genomic studies have indicated that the pathways mostly deregulated by ROR2 are phosphatidylinositol 3-kinase (PI3K)/AKT and mTOR [14]. Here, AKT1 is linked to cancer.